The Nasdaq marked its biggest intraday comeback since April as Wall Street bought the dip in some key technology and artificial intelligence stocks.

Bristol said it had decided to stop one of its ongoing Phase 3 trials testing an experimental blood thinner called milvexian.

Ominous clouds gathered on Wall Street this week—and may have passed just as quickly. It’s a sign that investors aren’t ready ...

The former Merrill executive and head of Sanctuary Wealth explains the strategy behind his new firm.

Privately held defense startup Anduril is working with HD Hyundai Heavy Industries on autonomous surface vessels for the U.S.

Power is now the way to invest in AI. Natural gas players and companies that upgrade the grid are on the radar of Gavekal ...

Stock indexes in the U.S. closed mixed Friday as the added 0.13%. Meanwhile, the 0.05%, and the declined 0.65%.

The Nasdaq marked its biggest intraday comeback since April as Wall Street bought the dip in some key technology and artificial intelligence stocks. The Nasdaq Composite rose 0.1%. The Dow Jones ...